Evidence map›Paper›PMID 34907912›Full record

ArticleThe Journal of clinical investigation2021

Deciphering regulatory protein activity in human pancreatic islets via reverse engineering of single-cell sequencing data.

Yumi Imai

Open access · bronzeAbstract readComment
In one paragraph

Article in The Journal of clinical investigation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Yumi ImaiDivision of Endocrinology and Metabolism, Department of Internal Medicine, and.
University of Iowa · US

Funding

Vector Core-Core 2P30DK054759 · NIDDK · UNIVERSITY OF IOWA · PI Amy Leanne Ryan · 1998 to 2026
$30.5M
Role of Lipid Droplet Proteins in Islet Function in Diabetes and ObesityR01DK090490 · NIDDK · UNIVERSITY OF IOWA · PI IMAI, YUMI · 2011 to 2025
$5.0M
A role and regulation of glucose responsive lipolysis in pancreatic beta cellsI01BX005107 · VA · IOWA CITY VA MEDICAL CENTER · PI IMAI, YUMI · 2021 to 2024
–
BLRD VA I01 BX005107NIDDK NIH HHS P30 DK054759NIDDK NIH HHS R01 DK090490
6 · The paper itself

Abstract

The loss of functional β cell mass contributes to development and progression of type 2 diabetes (T2D). However, the molecular mechanisms differentiating islet dysfunction in T2D from nondiabetic states remain elusive. In this issue of the JCI, Son et al. applied reverse engineering to obtain the activity of gene expression regulatory proteins from single-cell RNA sequencing data of nondiabetic and T2D human islets. The authors identify unique patterns of regulatory protein activities associated with T2D. Furthermore, BACH2 emerged as a potential transcription factor that drives activation of T2D-associated regulatory proteins in human islets.

Indexed as

Diabetes Mellitus, Type 2Insulin-Secreting CellsIslets of LangerhansGene Expression RegulationHumansTranscription FactorsTranscription Factors

Identifiers

PMID34907912
PMCPMC8670832
OpenAlexW4200136552

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.